References
- Sung H , FerlayJ , SiegelRLet al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin.71(3), 209–249 (2021).
- Biller LH , SchragD. Diagnosis and treatment of metastatic colorectal cancer: a review. JAMA325(7), 669–685 (2021).
- Siegel RL , WagleNS , CercekA , SmithRA , JemalA. Colorectal cancer statistics, 2023. CA Cancer J. Clin.73(3), 233–254 (2023).
- Benson AB , VenookAP , Al-HawaryMMet al. Colon cancer, version 2.2021, NCCN clinical practice guidelines in oncology. JNCCN19(3), 329–359 (2021).
- Zhang Y , DoranC , LeTKet al. Adverse events and clinical outcomes in patients treated with PD-(L)1 blockade for advanced non-small-cell lung cancer. Future Oncol.18(40), 4509–4523 (2022).
- Siriwardena AK , MasonJM , MullamithaS , HancockHC , JegatheeswaranS. Management of colorectal cancer presenting with synchronous liver metastases. Nat. Rev. Clin. Oncol.11(8), 446–459 (2014).
- Yamashita S , BrudvikKW , KopetzSEet al. Embryonic origin of primary colon cancer predicts pathologic response and survival in patients undergoing resection for colon cancer liver metastases. Ann. Surg.267(3), 514–520 (2018).
- Colloca GA , VenturinoA , GuarneriD. Different variables predict the outcome of patients with synchronous versus metachronous metastases of colorectal cancer. Clin. Transl. Oncol.22(8), 1399–1406 (2020).
- Slesser AA , GeorgiouP , BrownG , MudanS , GoldinR , TekkisP. The tumour biology of synchronous and metachronous colorectal liver metastases: a systematic review. Clin. Exp. Metastasis30(4), 457–470 (2013).
- Hoppener DJ , NieropPMH , Van AmerongenMJet al. The disease-free interval between resection of primary colorectal malignancy and the detection of hepatic metastases predicts disease recurrence but not overall survival. Ann. Surg. Oncol.26(9), 2812–2820 (2019).
- Awad MM , LiuS , RybkinIIet al. Acquired resistance to KRAS(G12C) inhibition in cancer. N. Engl. J. Med.384(25), 2382–2393 (2021).
- Aziz H , AhmedZ , LeeY , DrummG , SaifMW. A comprehensive review of management of colorectal liver mets in the current Era. Cancer Med. J.5(1), 46–57 (2022).
- Lee SY , HaqF , KimDet al. Comparative genomic analysis of primary and synchronous metastatic colorectal cancers. PLOS One9(3), e90459 (2014).
- Wei Q , YeZ , ZhongXet al. Multiregion whole-exome sequencing of matched primary and metastatic tumors revealed genomic heterogeneity and suggested polyclonal seeding in colorectal cancer metastasis. Ann. Oncol.28(9), 2135–2141 (2017).
- Sutton PA , JitheshPV , JonesRPet al. Exome sequencing of synchronously resected primary colorectal tumours and colorectal liver metastases to inform oncosurgical management. Eur. J. Surg. Oncol.44(1), 115–121 (2018).
- Mogensen MB , RossingM , OstrupOet al. Genomic alterations accompanying tumour evolution in colorectal cancer: tracking the differences between primary tumours and synchronous liver metastases by whole-exome sequencing. BMC Cancer18(1), 752 (2018).
- Shiomi A , KusuharaM , SuginoTet al. Comprehensive genomic analysis contrasting primary colorectal cancer and matched liver metastases. Oncol. Lett.21(6), 466 (2021).
- Hlavac V , CervenkovaL , SusovaSet al. Exome sequencing of paired colorectal carcinomas and synchronous liver metastases for prognosis and therapy prediction. JCO Precis. Oncol.7, e2200557 (2023).
- Horak J , KubecekO , SiskovaAet al. Differences in genome, transcriptome, miRNAome, and methylome in synchronous and metachronous liver metastasis of colorectal cancer. Front. Oncol.13, 1133598 (2023).
- Mosele F , RemonJ , MateoJet al. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group. Ann. Oncol.31(11), 1491–1505 (2020).